Bausch Health Companies Inc. (FRA:BVF)

Market Cap	2.18B
Revenue (ttm)	8.55B
Net Income (ttm)	308.53M
Shares Out	n/a
EPS (ttm)	0.82
PE Ratio	7.05
Forward PE	1.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20
Average Volume	578
Open	5.52
Previous Close	n/a
Day's Range	5.52 - 5.54
52-Week Range	3.99 - 7.71
Beta	n/a
RSI	44.81
Earnings Date	Feb 19, 2026

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern...

• Industry: Pharmaceutical Preparations
• CEO: Thomas Appio
• Employees: 20,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BVF

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD